New Insights on Lipedema: The Enigmatic Disease of the Peripheral Fat

As cardiovascular and cerebrovascular diseases remain a major cause of death globally, it is necessary to identify all their risk factors to improve public health and reduce their societal burden.

Chronic Stress: A Critical Risk Factor for Atherosclerosis

As cardiovascular and cerebrovascular diseases remain a major cause of death globally, it is necessary to identify all their risk factors to improve public health and reduce their societal burden.

The Clinical Effect Of Arrhythmia Monitoring After Myocardial Infarction (BIO-GUARD-MI): Study Protocol For A Randomized Controlled Trial

Even though the prognosis after myocardial infarction (MI) has improved much over recent decades due to improved and faster revascularization, platelet inhibition, and device therapy, a proportion of post-acute MI (AMI) patients with additional risk factors remain at high risk, with 5-year mortality ranging from 15% to 45% depending on the population.

Early Continuous Ultrafiltration in Chinese Patients with Congestive Heart Failure (EUC-CHF): Study Protocol for an Open-Label Registry-Based Prospective Clinical Trial

Pp to 30% of the patients with decompensated HF (NYHA classification III to IV) present with LDs resistance.

Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study

Patients with Multisite artery disease (MSAD) are regularly encountered in clinical practice and their prognosis is poorer than that of patients with just one territory affected.

Mindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 Single-Arm Clinical Trial

Global estimates show that a large proportion of society worldwide (31% of adults) had Stage 2 hypertension (>140/90 mmHg) in 2010.